
VAIs are clinically significant, costing over $2.5 billion in healthcare costs each year due to prolonged hospital stays and treatments. Despite these challenges, current knowledge on how these infections develop, especially in children, remains poorly understood. We aim to fill this knowledge gap and advance the prevention and treatment of VAIs to improve patient outcomes.
In the Rapsinski Lab, we investigate how the Gram-negative bacteria Pseudomonas aeruginosa colonizes and persists in the airway of pediatric patients who require mechanical ventilation. We use clinical isolates from UPMC Children's Hospital to examine adaptations of P. aeruginosa to the ventilated airway environment. We also use in vitro evolution models to understand how the nutritional environment of the ventilated airway contributes to these bacterial adaptations.
Our current work focuses on the complicated interplay between P. aeruginosa and the airway epithelium. Using air-liquid interface cultures of primary airway epithelial cells, we examine how changes in the host epithelium during ventilation affect the ability of P. aeruginosa to colonize and persist. These findings will help inform clinical care for children with ventilator-associated infections (VAIs).
Affiliated Faculty and Staff
Glenn Rapsinski, MD, PhD, Principal Investigator
Jacob Scioli, MPH, Research Technician
Amanda Riegel, Research Technician
